| Sign In to gain access to subscriptions and/or personal tools. |
MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?Max-Planck Institut für Immunbiologie, Freiburg, Germany
Max-Planck Institut für Immunbiologie, Freiburg, Germany
Immunobiology Research Group, GBF, Braunschweig, Germany
Department of Immunology, Faculty of Medicina, Policlinico University, Bari, Italy
Max-Planck Institut für Immunbiologie, Freiburg, Germany Although some activities of LPS are shared by other bacterial components, for half a century LPS has been regarded as unique in displaying many pathophysiological activities. Here we report on a synthetic lipopeptide, MALP-2 from Mycoplasma fermentans , which expresses potent endotoxin-like activity and whose lethal toxicity is comparable to that of LPS. With the exception of the Limulus lysate gelation test, in which MALP-2 was approximately 1000-fold less active than LPS, the synthetic lipopeptide induced all activities tested for, and in most cases to an extent comparable to that of LPS. Unlike LPS, the biological activities of MALP-2 were expressed both in LPSresponder and in LPS-non-responder mice (BALB/c/l, C57BL10/ScCr), indicating that MALP-2 signaling, unlike that of LPS, is not transduced via the Toll-like receptor (Tlr) 4 protein. MALP-2 expressed no toxicity in normal or sensitized Tlr2 knockout (Tlr2 /) mice indicating that its toxic activity is induced via Tlr2 signaling. The phenomenology of the lethal shock induced by MALP-2 in normal or sensitized mice, i.e. the kinetics of its development and symptoms of illness exhibited by the treated animals, was very reminiscent of the lethal shock induced by LPS.
Journal of Endotoxin Research, Vol. 6, No. 6,
471-476 (2000) |
|||